Financhill
Sell
36

DHI Quote, Financials, Valuation and Earnings

Last price:
$139.67
Seasonality move :
5.53%
Day range:
$137.30 - $140.77
52-week range:
$133.02 - $199.85
Dividend yield:
0.93%
P/E ratio:
9.72x
P/S ratio:
1.26x
P/B ratio:
1.77x
Volume:
7.2M
Avg. volume:
2.9M
1-year change:
-6.55%
Market cap:
$44.8B
Revenue:
$36.8B
EPS (TTM):
$14.36
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $20.3B $27.8B $33.5B $35.5B $36.8B
Revenue Growth (YoY) 15.45% 36.74% 20.54% 5.92% 3.78%
 
Cost of Revenues $15.4B $19.9B $23B $26.1B $27.3B
Gross Profit $4.9B $7.9B $10.5B $9.4B $9.5B
Gross Profit Margin 24.31% 28.35% 31.37% 26.37% 25.91%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2B $2.6B $2.9B $3.2B $3.6B
Other Inc / (Exp) $92.9M $37.5M $59.3M $213.1M $348.8M
Operating Expenses $2B $2.6B $2.9B $3.2B $3.6B
Operating Income $2.9B $5.3B $7.6B $6.1B $5.9B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $3B $5.4B $7.6B $6.3B $6.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $602.5M $1.2B $1.7B $1.5B $1.5B
Net Income to Company $2.4B $4.2B $5.9B $4.8B $4.8B
 
Minority Interest in Earnings -$6.8M -$15.4M -$38.1M -$49.5M -$49.6M
Net Income to Common Excl Extra Items $2.4B $4.2B $5.9B $4.7B $4.8B
 
Basic EPS (Cont. Ops) $6.49 $11.56 $16.65 $13.93 $14.44
Diluted EPS (Cont. Ops) $6.41 $11.41 $16.51 $13.82 $14.34
Weighted Average Basic Share $365.5M $361.1M $351.7M $340.7M $329.5M
Weighted Average Diluted Share $370.2M $365.8M $354.8M $343.3M $331.6M
 
EBITDA $3B $5.4B $7.7B $6.2B $6B
EBIT $2.9B $5.3B $7.6B $6.1B $5.9B
 
Revenue (Reported) $20.3B $27.8B $33.5B $35.5B $36.8B
Operating Income (Reported) $2.9B $5.3B $7.6B $6.1B $5.9B
Operating Income (Adjusted) $2.9B $5.3B $7.6B $6.1B $5.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.4B $8.1B $9.6B $10.5B $10B
Revenue Growth (YoY) 27.02% 26.7% 18.87% 8.97% -4.77%
 
Cost of Revenues $4.8B $5.7B $6.8B $7.7B $7.4B
Gross Profit $1.6B $2.4B $2.9B $2.8B $2.6B
Gross Profit Margin 25.73% 29.67% 29.86% 26.88% 25.54%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $597.7M $693M $832.1M $886.2M $960.3M
Other Inc / (Exp) $7M $13.4M $19.5M $81.2M $115.7M
Operating Expenses $597.7M $693M $832.1M $886.2M $960.3M
Operating Income $1B $1.7B $2B $1.9B $1.6B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $1.1B $1.7B $2.1B $2B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $224.9M $381M $417.6M $492.8M $409.9M
Net Income to Company $831.2M $1.3B $1.6B $1.5B $1.3B
 
Minority Interest in Earnings -$2.2M -$6.5M -$16.4M -$15.8M -$16.4M
Net Income to Common Excl Extra Items $829M $1.3B $1.6B $1.5B $1.3B
 
Basic EPS (Cont. Ops) $2.28 $3.74 $4.70 $4.49 $3.95
Diluted EPS (Cont. Ops) $2.24 $3.70 $4.67 $4.45 $3.92
Weighted Average Basic Share $364M $357.8M $346.9M $336.5M $325.3M
Weighted Average Diluted Share $369.6M $361.9M $349.7M $339.1M $327.4M
 
EBITDA $1.1B $1.7B $2.1B $2B $1.6B
EBIT $1B $1.7B $2B $1.9B $1.6B
 
Revenue (Reported) $6.4B $8.1B $9.6B $10.5B $10B
Operating Income (Reported) $1B $1.7B $2B $1.9B $1.6B
Operating Income (Adjusted) $1B $1.7B $2B $1.9B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $20.3B $27.8B $33.5B $35.5B $36.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $15.4B $19.9B $23B $26.1B $27.3B
Gross Profit $4.9B $7.9B $10.5B $9.4B $9.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2B $2.6B $2.9B $3.2B $3.6B
Other Inc / (Exp) $93.1M $37.4M $59.4M $213.3M $348.8M
Operating Expenses $2B $2.6B $2.9B $3.2B $3.6B
Operating Income $2.9B $5.3B $7.6B $6.1B $5.9B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $3B $5.4B $7.6B $6.3B $6.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $602.5M $1.2B $1.7B $1.5B $1.5B
Net Income to Company $2.4B $4.2B $5.9B $4.8B $4.8B
 
Minority Interest in Earnings -$6.9M -$15.3M -$38.1M -$49.4M -$49.5M
Net Income to Common Excl Extra Items $2.4B $4.2B $5.9B $4.7B $4.8B
 
Basic EPS (Cont. Ops) $6.50 $11.58 $16.68 $13.96 $14.45
Diluted EPS (Cont. Ops) $6.42 $11.43 $16.54 $13.84 $14.36
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3B $5.4B $7.7B $6.2B $6B
EBIT $2.9B $5.3B $7.6B $6.1B $5.9B
 
Revenue (Reported) $20.3B $27.8B $33.5B $35.5B $36.8B
Operating Income (Reported) $2.9B $5.3B $7.6B $6.1B $5.9B
Operating Income (Adjusted) $2.9B $5.3B $7.6B $6.1B $5.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $27.8B $33.5B $35.5B $36.8B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $19.9B $23B $26.1B $27.3B --
Gross Profit $7.9B $10.5B $9.4B $9.5B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.6B $2.9B $3.2B $3.6B --
Other Inc / (Exp) $37.4M $59.4M $213.3M $348.8M --
Operating Expenses $2.6B $2.9B $3.2B $3.6B --
Operating Income $5.3B $7.6B $6.1B $5.9B --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $5.4B $7.6B $6.3B $6.3B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2B $1.7B $1.5B $1.5B --
Net Income to Company $4.2B $5.9B $4.8B $4.8B --
 
Minority Interest in Earnings -$15.3M -$38.1M -$49.4M -$49.5M --
Net Income to Common Excl Extra Items $4.2B $5.9B $4.7B $4.8B --
 
Basic EPS (Cont. Ops) $11.58 $16.68 $13.96 $14.45 --
Diluted EPS (Cont. Ops) $11.43 $16.54 $13.84 $14.36 --
Weighted Average Basic Share $1.4B $1.4B $1.4B $1.3B --
Weighted Average Diluted Share $1.5B $1.4B $1.4B $1.3B --
 
EBITDA $5.4B $7.7B $6.2B $6B --
EBIT $5.3B $7.6B $6.1B $5.9B --
 
Revenue (Reported) $27.8B $33.5B $35.5B $36.8B --
Operating Income (Reported) $5.3B $7.6B $6.1B $5.9B --
Operating Income (Adjusted) $5.3B $7.6B $6.1B $5.9B --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3B $3.2B $2.5B $3.9B $4.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory $12.2B $16.5B $21.7B $22.4B $24.9B
Prepaid Expenses $46M $51.6M $77.4M $93M $117.9M
Other Current Assets -- -- -- -- --
Total Current Assets $17.8B $23.2B $28.8B $31.2B $34.7B
 
Property Plant And Equipment $104.4M $114.6M $144.4M $64.6M $70M
Long-Term Investments -- -- -- -- --
Goodwill $163.5M $163.5M $163.5M $163.5M $163.5M
Other Intangibles $17.1M $4.1M $10.6M $11.1M $5.9M
Other Long-Term Assets $34.6M $41.2M $339M $399.9M $391.8M
Total Assets $18.9B $24B $30.4B $32.6B $36.1B
 
Accounts Payable $900.5M $1.2B $1.4B $1.2B $1.3B
Accrued Expenses $129.2M $292.7M $437.4M $387.2M $486M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.2B $1.8B $2.2B $2.1B $2B
 
Long-Term Debt $4.3B $5.4B $6.1B $5.1B $5.9B
Capital Leases -- -- -- -- --
Total Liabilities $6.8B $8.8B $10.6B $9.4B $10.3B
 
Common Stock $3.9M $4M $4M $4M $4M
Other Common Equity Adj -- -- -- -- --
Common Equity $11.8B $14.9B $19.4B $22.7B $25.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $281.5M $329.7M $389.3M $441.7M $511.6M
Total Equity $12.1B $15.2B $19.8B $23.1B $25.8B
 
Total Liabilities and Equity $18.9B $24B $30.4B $32.6B $36.1B
Cash and Short Terms $3B $3.2B $2.5B $3.9B $4.5B
Total Debt $4.3B $5.4B $6.1B $5.1B $5.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3B $3.2B $2.5B $3.9B $4.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory $12.2B $16.5B $21.7B $22.4B $24.9B
Prepaid Expenses $46M $51.6M $77.4M $93M $117.9M
Other Current Assets -- -- -- -- --
Total Current Assets $17.8B $23.2B $28.8B $31.2B $34.7B
 
Property Plant And Equipment $104.4M $114.6M $144.4M $64.6M $70M
Long-Term Investments -- -- -- -- --
Goodwill $163.5M $163.5M $163.5M $163.5M $163.5M
Other Intangibles $17.1M $4.1M $10.6M $11.1M $5.9M
Other Long-Term Assets $34.6M $41.2M $339M $399.9M $391.8M
Total Assets $18.9B $24B $30.4B $32.6B $36.1B
 
Accounts Payable $900.5M $1.2B $1.4B $1.2B $1.3B
Accrued Expenses $129.2M $292.7M $437.4M $387.2M $486M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.2B $1.8B $2.2B $2.1B $2B
 
Long-Term Debt $4.3B $5.4B $6.1B $5.1B $5.9B
Capital Leases -- -- -- -- --
Total Liabilities $6.8B $8.8B $10.6B $9.4B $10.3B
 
Common Stock $3.9M $4M $4M $4M $4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $281.5M $329.7M $389.3M $441.7M $511.6M
Total Equity $12.1B $15.2B $19.8B $23.1B $25.8B
 
Total Liabilities and Equity $18.9B $24B $30.4B $32.6B $36.1B
Cash and Short Terms $3B $3.2B $2.5B $3.9B $4.5B
Total Debt $4.3B $5.4B $6.1B $5.1B $5.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.4B $4.2B $5.9B $4.8B $4.8B
Depreciation & Amoritzation $90.6M $82.1M $81.4M $91.6M $87.1M
Stock-Based Compensation $77.8M $91.4M $105.1M $111.2M $118.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$1.1B -$3.8B -$5.2B -$516.4M -$2.6B
Cash From Operations $1.4B $534.4M $561.8M $4.3B $2.2B
 
Capital Expenditures $286.8M $267.4M $148.2M $148.6M $165.3M
Cash Acquisitions -$9.7M -$24.5M -$271.5M -$212.9M -$40.4M
Cash From Investing -$166.1M -$252.2M -$414.9M -$310.2M -$190.6M
 
Dividends Paid (Ex Special Dividend) -$256M -$289.3M -$316.5M -$341.2M -$395.2M
Special Dividend Paid
Long-Term Debt Issued $2.6B $1.9B $4.4B $762.3M $2.1B
Long-Term Debt Repaid -$1.7B -$826.3M -$3.8B -$1.8B -$1.2B
Repurchase of Common Stock -$398.6M -$926.9M -$1.2B -$1.2B -$1.9B
Other Financing Activities -$5.1M -$2.4M $91.4M -$54.8M -$23.7M
Cash From Financing $270.6M -$85.1M -$811.2M -$2.7B -$1.4B
 
Beginning Cash (CF) $1.5B $3B $3.2B $2.6B $3.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5B $197.1M -$664.3M $1.3B $643.9M
Ending Cash (CF) $3B $3.2B $2.6B $3.9B $4.5B
 
Levered Free Cash Flow $1.1B $267M $413.6M $4.2B $2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $831.2M $1.3B $1.6B $1.5B $1.3B
Depreciation & Amoritzation $33.2M $18.5M $21.2M $21.4M $23.6M
Stock-Based Compensation $18.6M $21.7M $25.7M $30.6M $25.4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$99.3M -$473.6M $13.6M $599.7M $601M
Cash From Operations $832.7M $568.9M $1.1B $2B $2B
 
Capital Expenditures $66.4M $47.5M $40.2M $40.3M $32M
Cash Acquisitions -$3.6M -$100K -- -$10.9M -$2.5M
Cash From Investing -$65.7M -$45.3M -$42M -$1.7M -$29.5M
 
Dividends Paid (Ex Special Dividend) -$63.7M -$71.6M -$78.1M -$84.3M -$97.7M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$40.5M $989.5M $1.7B $120M $794.5M
Long-Term Debt Repaid -$3.4M $5.5M -$1.7B -$1.1B -$551.2M
Repurchase of Common Stock -- -$187M -$272M -$419.1M -$558.2M
Other Financing Activities -$400K -- $62.2M -$24.1M -$3.9M
Cash From Financing -$99.6M $744.5M -$194M -$1.5B -$408.1M
 
Beginning Cash (CF) $2.4B $2B $1.7B $3.4B $3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $667.4M $1.3B $888.6M $492.1M $1.5B
Ending Cash (CF) $3B $3.2B $2.6B $3.9B $4.5B
 
Levered Free Cash Flow $766.3M $521.4M $1.1B $2B $1.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.4B $4.2B $5.9B $4.8B $4.8B
Depreciation & Amoritzation $90.6M $82.1M $81.4M $91.6M $87.1M
Stock-Based Compensation $77.8M $91.4M $105.1M $111.2M $118.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$1.1B -$3.8B -$5.2B -$516.4M -$2.6B
Cash From Operations $1.4B $534.4M $561.8M $4.3B $2.2B
 
Capital Expenditures $286.8M $267.4M $148.2M $148.6M $165.3M
Cash Acquisitions -$9.7M -$24.5M -$271.5M -$212.9M -$40.4M
Cash From Investing -$166.1M -$252.2M -$414.9M -$310.2M -$190.6M
 
Dividends Paid (Ex Special Dividend) -$256M -$289.3M -$316.5M -$341.2M -$395.2M
Special Dividend Paid
Long-Term Debt Issued $2.6B $1.9B $4.4B $762.3M $2.1B
Long-Term Debt Repaid -$1.7B -$826.3M -$3.8B -$1.8B -$1.2B
Repurchase of Common Stock -$398.6M -$926.9M -$1.2B -$1.2B -$1.9B
Other Financing Activities -$5.1M -$2.4M $91.4M -$54.8M -$23.7M
Cash From Financing $270.6M -$85.1M -$811.2M -$2.7B -$1.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5B $197.1M -$664.3M $1.3B $643.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.1B $267M $413.6M $4.2B $2B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $4.2B $5.9B $4.8B $4.8B --
Depreciation & Amoritzation $82.1M $81.4M $91.6M $87.1M --
Stock-Based Compensation $91.4M $105.1M $111.2M $118.1M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$3.8B -$5.2B -$516.4M -$2.6B --
Cash From Operations $534.4M $561.8M $4.3B $2.2B --
 
Capital Expenditures $267.4M $148.2M $148.6M $165.3M --
Cash Acquisitions -$24.5M -$271.5M -$212.9M -$40.4M --
Cash From Investing -$252.2M -$414.9M -$310.2M -$190.6M --
 
Dividends Paid (Ex Special Dividend) -$289.3M -$316.5M -$341.2M -$395.2M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.9B $4.4B $762.3M $2.1B --
Long-Term Debt Repaid -$826.3M -$3.8B -$1.8B -$1.2B --
Repurchase of Common Stock -$926.9M -$1.2B -$1.2B -$1.9B --
Other Financing Activities -$2.4M $91.4M -$54.8M -$23.7M --
Cash From Financing -$85.1M -$811.2M -$2.7B -$1.4B --
 
Beginning Cash (CF) $9.7B $9.1B $11.7B $13.4B --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $197.1M -$664.3M $1.3B $643.9M --
Ending Cash (CF) $9.9B $8.4B $13B $14B --
 
Levered Free Cash Flow $267M $413.6M $4.2B $2B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock